Ochre Bio Company
Ochre Bio is developing therapies for the biggest liver health challenges.
Investors
.png)
Connections from
Funding Status:
Early Stage Venture
Industry:
Early Drug Development
Estimated Revenue:
Less than $1M
Technology:
Biopharma, Biotechnology, Health Care, Therapeutics
Headquarters:
Oxford, Oxfordshire, United Kingdom
Total Funding:
39750000.0
Last Funding Date:
2022-10-10
Last Funding Type:
Series A
Employee Number:
11-50
Investors Number:
19.0
Founded Date:
2019-09-01